|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
CA2404002A1
(en)
|
2000-03-24 |
2001-09-27 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
JPWO2002074298A1
(ja)
|
2001-03-21 |
2004-07-08 |
小野薬品工業株式会社 |
Ｉｌ−６産生阻害剤
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
WO2003037869A1
(en)
|
2001-11-01 |
2003-05-08 |
Janssen Pharmaceutica N.V. |
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
JP2006520796A
(ja)
|
2003-03-17 |
2006-09-14 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼインヒビター
|
|
CA2561617A1
(en)
|
2004-04-05 |
2005-10-20 |
Aton Pharma, Inc. |
Histone deacetylase inhibitor prodrugs
|
|
JP5744376B2
(ja)
|
2005-03-22 |
2015-07-08 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
タンパク質分解障害の治療
|
|
US20070155730A1
(en)
|
2005-08-26 |
2007-07-05 |
Methylgene, Inc. |
Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase
|
|
CN101400362B
(zh)
|
2006-02-14 |
2016-10-12 |
哈佛大学校长及研究员协会 |
双官能组蛋白去乙酰化酶抑制剂
|
|
CN101484156B
(zh)
|
2006-05-03 |
2015-11-25 |
哈佛大学校长及研究员协会 |
组蛋白脱乙酰基酶和微管蛋白脱乙酰基酶抑制剂
|
|
WO2007144341A1
(en)
|
2006-06-12 |
2007-12-21 |
Vrije Universiteit Brussel |
Differentiation of rat liver epithelial cells into hepatocyte-like cells
|
|
ES2288802B1
(es)
|
2006-07-07 |
2008-12-16 |
Universidad De Granada |
Nuevos derivados de ftalimida como inhibidores de las histonas desacetilasas.
|
|
JP5563300B2
(ja)
|
2006-09-11 |
2014-07-30 |
キュリス，インコーポレイテッド |
亜鉛結合部分を含むチロシンキナーゼインヒビター
|
|
KR101325374B1
(ko)
|
2008-02-19 |
2013-11-08 |
가부시키가이샤 오츠까 세이야꾸 고죠 |
신체 기능의 회복에 유용한 경구 또는 경장 조성물
|
|
RU2515611C2
(ru)
|
2008-07-23 |
2014-05-20 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Ингибиторы деацетилазы и их применение
|
|
US8716326B2
(en)
|
2009-05-15 |
2014-05-06 |
Korea Research Institute Of Chemical Technology |
Isoindolinone derivatives, preparation method thereof and a pharmaceutical composition comprising same
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
WO2011084991A2
(en)
|
2010-01-08 |
2011-07-14 |
President And Fellows Of Harvard College |
Fluorinated hdac inhibitors and uses thereof
|
|
SG182646A1
(en)
|
2010-01-22 |
2012-08-30 |
Acetylon Pharmaceuticals Inc |
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
|
|
AU2011255281A1
(en)
|
2010-05-21 |
2013-01-10 |
Sloan-Kettering Institute For Cancer Research |
Selective HDAC inhibitors
|
|
WO2012018499A2
(en)
|
2010-08-05 |
2012-02-09 |
Acetylon Pharmaceuticals |
Specific regulation of cytokine levels by hdac6 inhibitors
|
|
NZ610225A
(en)
|
2010-11-16 |
2015-08-28 |
Acetylon Pharmaceuticals Inc |
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
|
|
WO2013013113A2
(en)
|
2011-07-20 |
2013-01-24 |
The General Hospital Corporation |
Histone deacetylase 6 selective inhibitors for the treatment of bone disease
|
|
EP2839037B1
(en)
|
2012-04-19 |
2018-12-26 |
Acetylon Pharmaceuticals, Inc. |
Biomarkers to identify patients that will respond to treatment and treating such patients
|
|
WO2014059306A1
(en)
|
2012-10-12 |
2014-04-17 |
The Trustees Of The University Of Pennsylvania |
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
|
|
US9145412B2
(en)
|
2012-11-02 |
2015-09-29 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC1 and HDAC2 inhibitors
|
|
US9139583B2
(en)
|
2013-02-01 |
2015-09-22 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC3 inhibitors
|
|
US9096549B2
(en)
|
2013-02-01 |
2015-08-04 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC3 inhibitors
|
|
WO2014197471A1
(en)
|
2013-06-03 |
2014-12-11 |
Acetylon Pharmaceuticals, Inc. |
Histone deacetylase ( hdac) biomarkers in multiple myeloma
|
|
JP2016531163A
(ja)
|
2013-09-20 |
2016-10-06 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
Ｈｄａｃ６阻害物質を用いた、異常なリンパ球の機能に起因する疾患の治療
|
|
US9403779B2
(en)
|
2013-10-08 |
2016-08-02 |
Acetylon Pharmaceuticals, Inc. |
Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitors
|
|
ES2818933T3
(es)
|
2013-10-10 |
2021-04-14 |
Acetylon Pharmaceuticals Inc |
Inhibidores de la HDAC en combinación con los inhibidores de la pi3k, para el tratamiento del linfoma no Hodgkin
|
|
US9278963B2
(en)
|
2013-10-10 |
2016-03-08 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
|
|
WO2015054197A1
(en)
*
|
2013-10-10 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
Hdac inhibitors, alone or in combination with btk inhibitors, for treating non-hodgkin's lymphoma
|
|
CA2926808A1
(en)
|
2013-10-11 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
Combinations of histone deacetylase inhibitors and immunomodulatory drugs
|
|
EP3060217B1
(en)
*
|
2013-10-24 |
2022-06-08 |
Mayo Foundation for Medical Education and Research |
Treatment of polycystic diseases with an hdac6 inhibitor
|
|
CR20160308A
(es)
|
2013-12-03 |
2016-11-08 |
Acetylon Pharmaceuticals Inc |
Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
|
|
JP7017309B2
(ja)
|
2013-12-20 |
2022-02-08 |
アセチロン ファーマシューティカルズ インコーポレイテッド |
多発性骨髄腫におけるヒストン脱アセチル化酵素６（ｈｄａｃ６）バイオマーカー
|
|
US9464073B2
(en)
|
2014-02-26 |
2016-10-11 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
|
|
US20150359794A1
(en)
|
2014-06-13 |
2015-12-17 |
Buck Institute For Research On Aging |
Impairment of the large ribosomal subunit protein rpl24 by depletion or acetylation
|
|
AU2015288060A1
(en)
|
2014-07-07 |
2017-02-09 |
Acetylon Pharmaceuticals, Inc. |
Treatment of leukemia with histone deacetylase inhibitors
|
|
WO2016057779A2
(en)
|
2014-10-08 |
2016-04-14 |
Acetylon Pharmaceuticals, Inc. |
Induction of gata2 by hdac1 and hdac2 inhibitors
|
|
CN107438436A
(zh)
|
2014-12-05 |
2017-12-05 |
摩德纳和雷焦艾米利亚大学 |
用于治疗淋巴瘤的组蛋白脱乙酰酶抑制剂和苯达莫司汀的组合
|
|
US20160158231A1
(en)
|
2014-12-05 |
2016-06-09 |
Vib Vzw |
Pyrimidine hydroxy amide compounds for treating peripheral neuropathy
|
|
AU2015360270B9
(en)
|
2014-12-12 |
2019-12-05 |
Regenacy Pharmaceuticals, Llc |
Piperidine derivatives as HDAC1/2 inhibitors
|
|
WO2016168647A1
(en)
|
2015-04-17 |
2016-10-20 |
Acetylon Pharmaceuticals Inc. |
Treatment of neuroblastoma with histone deacetylase inhibotrs
|
|
US10272084B2
(en)
|
2015-06-01 |
2019-04-30 |
Regenacy Pharmaceuticals, Llc |
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
|
|
ES2769255T3
(es)
|
2015-06-08 |
2020-06-25 |
Acetylon Pharmaceuticals Inc |
Métodos para fabricar inhibidores de la proteína desacetilasa
|
